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ABSTRACT
Objective. Alcoholic liver disease (ALD) is one of the most important indications for
liver transplantation. Discordant conclusions have been found concerning quality of life
and mental health after transplantation in this particular group. The aim of this work was
to investigate improvements in mental health and quality of life among transplanted
patients for ALD.
Methods. We studied 45 consecutive transplant candidates with ALD, attending the
outpatient clinics. Among these patients we transplanted 24 with the control candidates
remaining in wait for transplantation.
Results. There was a significant improvement in all mental health and quality of life
dimensions among the transplanted ALD group. We also observed a favorable evolution
of coping mechanisms (CM) in this group.
Conclusion. There is a favorable adjustment of ALD patients after transplantation as
shown in CM evolution, which might explain the improved mental health and quality-of-
life dimensions.ALCOHOLIC LIVER DISEASE (ALD) is one of themost important indications for liver transplantation.
Between 1988 and 2004, 31% of liver transplants in Europe
were performed in patients with ALD and 17.2% between
1988 and 2006. Many authors have demonstrated similar
medical outcomes between alcoholic and non-alcoholic
liver transplant recipients.1–4 Discordant conclusions have
been reported concerning quality of life and mental health
after transplantation in this group.5–8 The aim of this work
was to investigate whether there was an improvement in




We studied 45 ALD transplant candidates, attending our outpa-
tient clinics between March 1, 2006 and December 1, 2007. Among
these, 28 were transplanted, of whom three died and one was
retransplanted. They were excluded from the study. Patients were
assessed before transplantation and 12 months thereafter. Patients
who remained waiting for transplantation (n 17) were the control
group. These patients were assessed twice—once at presentation
and a second time after 12 months.
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184The study protocol was approved by the institutional review
committee and written informed consent was obtained from all
participants.
Pre- and Posttransplant Psychosocial Assessment
To measure quality of life, we used the SF-36 Portuguese
validated version, a self-rating questionnaire developed by the
Medical Outcome Trust.9,10 Total values were computed for
physical and mental components of health-related quality of life.
Levels of anxiety and depression were assessed by means of the
Hospital Anxiety and Depression Scale Portuguese version.11,12
To access coping mechanisms, we used the Brief COPE Portu-
guese version,13,14 which was designed to yield quick, reliable, and
valid measures of the 14 domains of coping strategies: self-
From the Faculty of Medicine (D.T.-C., A.B., E.M.), University of
Lisbon, Lisbon, Portugal; and Curry Cabral Hospital’s Liver Trans-
plantation Center (D.T.-C., I.M., E.M., E.B.), Lisbon, Portugal.
Address reprint requests to Dr Diogo Telles-Correia, Rua
Sacadura Cabral No. 55, 4° B, 1495 Cruz Quebrada-Dafundo,
Portugal. E-mail: tellesdiogo@gmail.com
© 2011 by Elsevier Inc. All rights reserved.
360 Park Avenue South, New York, NY 10010-1710
Transplantation Proceedings, 43, 184–186 (2011)
S47.3
QOL IN ALCOHOL LIVER DISEASE PATIENTS 185distraction, active coping, denial, substance use, use of emotional
support, use of instrumental support, behavioral disengagement,
venting, positive reframing, planning, humor, acceptance, religions
and self-blame.
Statistical Methods
Statistical analysis was performed with the SPSS 13.0 for Windows
software package. Statistical difference between transplanted and
nontransplanted patients were evaluated by discriminant analysis
using Wilk’s lambda.
RESULTS
Pre- and posttransplantation scores among control and
study groups are represented in Table 1. By means of
discriminant analysis, we observed no differences be-
tween study and control group regarding pretransplant
variables.
Concerning posttransplant scores, we noted significant
differences between the two groups among all variables,
namely, anxiety, depression, physical quality of life, and
mental quality of life. A significant discriminant function
was found: 2  60.02 (P  .00). This means that scores for
anxiety and depression were significantly lower among ALD
transplanted patients with significantly higher quality-of-life
scores (Table 2).
Based on the Moos and Shaefer model, which links
quality of life and mental health to coping strategies, we
sought to analyze coping strategies in ALD patients after
transplantation. Within the whole sample, we observed
the scores for adaptive coping strategies, such as active
coping, positive reframing, and acceptance, to be in-
creased after transplantation. The opposite finding were
Table 2. Differences Between Transplanted and
Nontransplanted Groups
HADS and SF-36
Posttransplant Wilks’ Lambda F P
HADS
Anxiety .70 20.90 .00
Depression .80 18.35 .00
SF-36
Physical component .50 80.34 .00
Mental component .80 19.10 .00
Table 1. Mean Scores Fr
HADS and SF-36
Pretransplantation
Study Group (n  24) C
HADS
Anxiety 7.58  4.00
Depression 5.49  4.10
F-36
Physical component 47.00  22.20 4
Mental component 48.33  20.00Abbreviations: HADS, Hospital Anxiety and Depression Scale; SF-36, 36-item
Medical Outcomes Study Short-Form General Health Survey.noted for nonadaptive coping strategies scores, such as
behavior disengagement, denial and self-blame (Table 3).
DISCUSSION
We concluded that there was a significant improvement in
mental health and quality of life among recipients trans-
planted for ALD. We showed one possible reason is the
improvement in adaptive coping mechanisms among these
patients.
These results may be important in social and moral
debates about the eligibility of ALD patients for transplan-
tation. Further studies are needed in a larger sample size.
(Table 2).
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